Clinical Trial Update: 18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for 18F-2-fluoro-2-deoxy-D-glucose in PET-CT related to solitary pulmonary nodule and oncology indications; status not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oncology
• Solitary Pulmonary Nodule

Drugs mentioned

• 18F-2-fluoro-2-deoxy-D-glucose (18F-FDG)

Snippet

Sponsor: Eastern Health, Canada | Conditions: Solitary Pulmonary Nodule, Oncology | Phase 3 | Status: NOT_YET_RECRUITING